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Available online 16 June 2016Visceral and subcutaneous adipose tissue depots have distinct features and contribute differentially to the
development of metabolic dysfunction. We show here that adipocyte differentiation in subcutaneous stromal-
vascular fraction (SVF) is increased compared to visceral SVF, however this increased differentiation capacity
seems not to be due to changes in the number of adipocyte precursor cells. Rather, we demonstrate that secreted
heat-sensitive factors from the SVF can inhibit adipocyte differentiation and that this effect is higher in visceral
than in subcutaneous SVF, suggesting that visceral SVF is a source of secreted factors that can inhibit adipocyte
formation. In order to explore secreted proteins that potentially inhibit differentiation in visceral preadipocytes
we analyzed the secretome of both SVFs which led to the identiﬁcation of 113 secreted proteins with an overlap
of 42%. Further expression analysis in both depots revealed 16 candidates that were subsequently analyzed in a
differentiation screen using an adenoviral knockdown system. From this analysis we were able to identify two
potential inhibitory candidates, namely decorin (Dcn) and Sparc-like 1 (Sparcl1). We could show that ablation
of either candidate enhanced adipogenesis in visceral preadipocytes, while treatment of primary cultures with
recombinant Sparcl1 andDcnblocked adipogenesis in a dose dependentmanner. In conclusion, our data suggests
that the differences in adipogenesis between depots might be due to paracrine and autocrine feedback
mechanisms which could in turn contribute to metabolic homeostasis.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Adipose tissue is an important regulator of lipid metabolism and
serves as a safe storage place for excess lipids in times of sufﬁcient
nutrient supply. Vice versa, adipocytes release free fatty acids during
fasting by lipolysis to supply other peripheral tissues with energy [1].
Apart from its role as a lipid sink, adipose tissue is also an endocrine
organ secreting adipokines, cytokines and hormones, which exert
paracrine effects on adipose tissue function as well as endocrine
regulation of whole body energy homeostasis [2].
In response to ﬂuctuations in energy supply, adipose tissue has
evolved into an extremely dynamic tissue being able to expand and
shrink in mass according to the nutritional status. To do so, adipocytes
have the unique capability to change size [3,4]. Additionally, adipocytes
are thought to have a constant turn-over rate [5] and new adipocytes
can form by de novo differentiation from adipocyte precursor cells
(APC), which contributes to adipose tissue plasticity and reside within
the stromal-vascular fraction (SVF) of adipose tissue [6]. Differentiationsse 16, 8603 Schwerzenbach,
m).
. This is an open access article underis not only determined by adipocyte progenitor numbers, but is also
largely inﬂuenced by external stimuli within the extracellular adipose
tissue milieu. Numerous examples of endocrine and paracrine factors
are known to inﬂuence adipogenesis, such as insulin, ﬁbroblast growth
factor and glucocorticoids promoting differentiation or TNFα, Wnt and
lysophosphatidic acid repressing differentiation, just to name a few
examples [7]. Extracellular matrix components also play an important
role either directly in cell shape modulation or by sequestering impor-
tant growth factors and possibly inﬂuencing the adipocyte progenitor
niche [8,9].
Whereas adipose tissue is extremely efﬁcient in storing energy for
times of scarce nutritional supply, the evolutionary more recent,
constant oversupply of food rich in calories can pose major functional
disturbances in adipose tissue. Excess adipose tissue in obesity is one
of the key features ofmetabolic syndrome increasing the risk to develop
type 2 diabetes and cardiovascular disease [10]. Of major importance
is the fact that hypertrophied adipocytes engorged with lipids
show dysregulated function with increased free fatty acid and pro-
inﬂammatory cytokine release, thus promoting dyslipidemia and
low-grade inﬂammation contributing to insulin resistance [4,11,12].
Therefore, fat cell size, which is determined by the balance between
de novo adipogenesis (leading to small adipocytes) and adipocyte
hypertrophy (giving rise to large cells) is an important factor thatthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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metabolic secondary complications is the location of excess adipose
tissue. Central adiposity with increased amounts of visceral fat poses a
greater metabolic risk factor than excess subcutaneous adipose tissue
[16]. Many reports underline the fact that subcutaneous and visceral
adipose tissue display distinct features such as different gene expres-
sion, higher lipolytic rate and decreased insulin sensitivity in visceral
adipose tissue [17]. This report links adipogenic potential of murine
SVF to adipocyte size of different fat depots. To shed light on the under-
lying mechanisms, adipocyte progenitor numbers as well as paracrine
factors secreted from SVF, whichmight affect the differentiation ability,
are analyzed in subcutaneous and visceral SVF. Using a mass spectrom-
etry approach, novel secreted factors from SVF are identiﬁed that inhibit
adipogenesis in primary SVF culture, thereby potentially contributing to
increased adipocyte hypertrophy.
2. Material and methods
2.1. Animals
C57Bl/6J male mice aged 12–14 weeks were obtained from Jackson
Laboratory and kept on a 12-h/12-h light/dark cycle in a pathogen-
free animal facility.
2.2. SVF isolation and adipocyte differentiation
Primary pre–adipocytes from inguinal and epididymal adipose tissue
as well as 3T3L1 ﬁbroblast were grown and differentiated as described
previously [9]. For SVF isolation, inguinal and epididymal fat pats were
dissected, minced and incubated with collagenase buffer containing
2mg/ml collagenase (Invitrogen) for 1 h at 37 °C on a shaker. Digested tis-
sues were resuspend with equal volume of DMEM supplemented with
10% Fetal Bovine Serum (FBS) and 1% Penicillin/Streptomycin (P/S) (all
Invitrogen) and centrifuged at 1000 rpm for 10 min to separate the SV
and the mature adipocyte fraction. Pelleted SV fraction was resuspend
in 10 ml DMEM supplemented with 10% FBS and 1% P/S and ﬁltered
through a 40 μm sieve. Filtered ﬂowthrough was centrifuged at
1000 rpm for 4 min. Pellet was incubated for 5 min with 5 ml erythro-
cyte lysis buffer and centrifuged at 1000 rpm for 4min. Final pellet con-
taining preadipocytes was resuspend with DMEM supplemented with
10% FBS and 1% P/S to required volume and seeded on collagen-
coated plates. For conditionedmedia experiments, SVF cells were seed-
ed on collagen-coated 6-well plates. After cells had attached, fresh
growthmediumwas added, collected after 48 h and used for differenti-
ation of inguinal and epididymal SVF. As a control, medium was incu-
bated at 37 °C in empty cell culture dishes for the same time. For heat
inactivation, collected supernatant was heated to 95 °C for 10 min.
2.3. Automated analysis of adipocyte differentiation
Differentiated cells were ﬁxed with 5% formaldehyde prior to stain-
ingwith BODIPY (2 μM) for lipid droplets, Hoechst (4 μM) for nuclei and
Syto60 (5 μM) for cytosolic staining (all Invitrogen). 12 pictures perwell
were takenwith an automatedmicroscope imaging system (CellWorx).
Pictures were analyzed using Cell Proﬁler Software as described previ-
ously [9]. In short, Hoechst staining was used to identify nuclei. Using
the Syto60 stain cells outlines were identiﬁed. In parallel lipid droplets
were identiﬁed using the BODIPY stain. Lipid droplets were assigned
to cells by localization and a cell was considered as an adipocyte if it
contained at least 3 lipid droplets.
2.4. Adipocyte cell size
Adipose tissue preparation, H&E staining and image acquisition and
analysis with Cell Proﬁler was performed as described before [15].2.5. Flow cytometry analysis of adipocyte precursor markers
SVF was stained with Ter119-Alexa488, CD45-Alexa488, CD31-
Alexa488 for Lin− selection, CD29-PE, CD34-Alexa647 and Sca1-PE-
Cy7 (all Biolegend). 7-AAD was added for live cell staining and cells
were analyzed on a FACSCanto II machine (BD). Data was analyzed
using FlowJo software.
2.6. Mass spectrometry analysis of supernatant from SVF
SVF were seeded as described before on collagen or poly-lysine
coated 6-well plates. After cells had attached, growth medium was
replaced by Opti-MEM and collected after 48 h. Collected superna-
tant was dialyzed against PBS, proteins were reduced with 5 mM
Tris 2 carboxyethyl phosphine (TCEP) and alkylated with 10 mM
iodoacetamide. Samples were digested with trypsin (Promega) in a
1:50 ratio for 12 h at room temperature. Peptides were desalted on
Ultra MicroTIP Columns (The Nest Group, Southborough, MA, USA) and
dried in a SpeedVac concentrator. Dried peptides were resolubilized in
20 μl HPLC grade water containing 0.1% formic acid.
Sample analysis was performed on a linear ion trap LTQ mass
spectrometer (Thermo Electron, San Jose, CA) equipped with a
nanoelectrospray ion source (Thermo Electron) coupled to an
Agilent 1100 μ HPLC system. Peptides were loaded with a cooled
Agilent autosampler on a 2 cm long pre-column ﬁlled with C18
resin (Magic C18 AQ 5 μm; Michrom Bioresources, Auburn, CA,
USA). A linear gradient of 80 min from 5% to 40% acetonitrile in
H2O with 0.1% formic acid was used to separate peptides on a
10 cm long fused silica emitter packed with C18 resin spraying
directly into the mass spectrometer at a ﬂow rate of 0.5 μl/min.
The MS instrument was operated in positive ion mode. The data-
dependent acquisition mode was set to acquire one MS scan followed
by three collision induced dissociation MS/MS scans. The MS full scans
were recorded over a mass range of 400–1600 m/z. Dynamic exclusion
was enabled, the repeat countwas set to 2 and the exclusion duration to
30 s. FurtherMS conditionswere set as following: spray voltage 1.95 kV,
transfer capillary temperature 230 °C, normalized collision energy 35%,
activation q 0.25 and activation time 30 ms.
The acquired raw ﬁles were converted to mzXML ﬁles using ReAdW
with default settings and searched against the mouse IPI database
version 3.26 with the Sequest search algorithm. The sequest search pa-
rameters contained the static modiﬁcation of cysteine +57.02 Da, at
least one tryptic terminus and one missed cleavage was allowed. The
data were further processed using the using the Trans-Proteomic Pipe-
line TPP including PeptideProphet and ProteinProphet to estimate the
false discovery rate in the datasets. A protein probability of 0.5 was set
as a cutoff corresponding to a false discovery rate of approximately 5%.
The protein list was annotated for secreted proteins using the
algorithm SignalP and further manually curated for secreted proteins
using UniProt database and literature search. Functional annotation
was assigned using the PANTHER Classiﬁcation system. Venndiagrams
were created with Vennmaster.
2.7. qPCR expression analysis
mRNA fromepididymal and inguinal SVF aswell as virus-infected 3T3-
L1 cells was isolated and transcribed to cDNA using theMultiMACS cDNA
Synthesis Kit (Miltenyi). mRNA expressionwas assessed by real-time PCR
using SybrGreen qPCR reagent (Invitrogen). Expression was normalized
to Gapdh and β-actin. For primer sequences see Suppl. Table 1.
2.8. Adenovirus screen
For adenoviral shRNA knockdown, shRNA-sequences were designed
using RNAidesigner (Invitrogen) and shRNA-oligos were cloned into
pENTR_U6 containing a modiﬁed linker with EcoRI and Age I restriction
Fig. 1. a) In vitro differentiation potential of plated inguinal and epididymal SVF induced with insulin, dexamethasone and IBMX and ﬁxed on day 7 of differentiation (n= 8). b) Confocal
microscopy pictures showing differentiated SVF stainedwith BODIPY for lipid droplets (green), Syto60 (red) and Hoechst (blue). c) Representative plot of ﬂuorescent staining of inguinal
SVFwith 7-aad for live cell staining, Ter119-Alexa488, CD45-Alexa488, andCD31-Alexa488 for Lin− selection, CD29-PE, CD34-Alexa647 and Sca1-PE-Cy7. Shownare example scatter plots
with gating on FSC/SSC and7-aad− cells (“all-live”), stainingwith allmarkers on the all-live population and sequential gating on Lin−CD29+CD34highSca1+ cells. c) Fluorescent staining of
epididymal SVFwith 7-aad for live cell staining, Ter119-Alexa488, CD45-Alexa488, and CD31-Alexa488 for Lin− selection, CD29-PE, CD34-Alexa647 and Sca1-PE-Cy7. Shown are example
scatter plotswith gating on FSC/SSC and 7-aad− cells (“all-live”), stainingwith allmarkers on the all-live population and sequential gating on Lin−CD29+CD34highSca1+cells. e) Schematic
and percentages of all-live population of Lin−CD29+CD34highSca1+ in inguinal and epididymal SVF (n = 4). *p b 0.05, ***p b 0.001.
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BLOCK-iT-DEST using LRII clonase (Invitrogen). Crude adenoviral stock
was produced transfecting HEK293A cells with 1 μg of PacI digested ade-
noviral plasmid according to the manufacturer's protocol. Crude viral ly-
sate was used to reinfect HEK293A cells and virus from lysed cells was
puriﬁed with the Adeno MINI Puriﬁcation ViraKit (Virapur).For infection, puriﬁed virus was diluted 1:10 in Opti-MEM with
0.0001% poly-L-lysine and incubated for 90 min at room temperature.
Cells were then incubated with diluted virus at 37 °C and after 2 h an
equal amount of medium was added. Virus-containing medium was
changed after 24 h and cells were induced for differentiation 48 h after
infection. Cells were ﬁxed, stained and analyzed as described above.
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Fig. 3. a) Venn-diagram of secreted proteins identiﬁed by mass spectrometry in the supernatant of inguinal and epididymal SVF. b) Functional panther classiﬁcation of all identiﬁed
proteins in the supernatant of inguinal and epididymal SVF. c) mRNA expression of selected proteins in inguinal and epididymal SVF, values are normalized to β-actin. (n = 4)
*p b 0.05 **p b 0.01 ***p b 0.001.
Fig. 2. a) Differentiation of inguinal and epididymal SVF using normal medium and conditioned medium from inguinal/epididymal SVF. Conditioned mediumwas either used directly or
heat-inactivated at 95 °C for 10 min. b) Confocal microscopy pictures showing differentiated SVF using normal medium and conditioned medium directly or heat-inactivated from
inguinal/epididymal SVF stained with BODIPY for lipid droplets (green), Syto60 (red) and Hoechst (blue). (n = 4) *p b 0.05, **p b 0.01, ***p b 0.001, Scale:100 μm SN:supernatant.
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ation for each cell type were performed. Percent differentiation was
normalized to mean differentiation of each round and cell type. Forevery shRNA a mean normalized differentiation over all rounds was
calculated for every cell type. Based on the outcome for the shRNA
scramble control, cut-off values were set for inguinal and epididymal
1127B. Meissburger et al. / Biochimica et Biophysica Acta 1861 (2016) 1121–1131cells. shRNAs enhancing or inhibiting differentiation were selected
based on the cut-off and the standard-deviation over all rounds.
2.9. Protein overexpression
For cloning of overexpression constructs, cDNA was ampliﬁed
from murine fat or 3T3 L1 cDNA (for primer sequences see Suppl.
Table 3) and ligated into pSecTagA containing an Igκ-leader
sequence for high protein secretion and a c-myc/his-tag for protein
puriﬁcation. cDNA was also cloned into pENTR_CMV_MCS_TkPA
(Invitrogen) adding a C-terminal HA-tag to produce adenoviral
overexpression constructs.
2.10. Western blot analysis
HEK293A cells were transfected with FuGENE (Roche) according to
the manufacturers protocol. Medium was changed to OptiMEM after
12 h. Cells were lysed and supernatant was collected after 48 h and
whole cell extract as well as supernatant was subjected to 12% SDS gel
and Western blotting using mouse anti-HA antibody (Covance) or
mouse anti-myc antibody (kind gift of Gudrun Christiansen).
2.11. Statistical analysis
Results are given as mean ± standard deviation. Statistical analyses
were performed using a Student's t-test as indicated.
3. Results
As cell size is an important determinant for adipocyte functionality
and tightly linked to metabolic control in the context of a whole organ-
ism, we quantiﬁed adipocyte size in the epididymal as well as in the
inguinal adipose tissue compartment of 12 weeks old C57Bl6 mice. As
reported previously, we observed that adipocytes in the epididymal
fat pad were signiﬁcantly larger by approximately 22% than in inguinal
adipose tissue. Since adipocyte size is determined by a balance between
adipocyte hypertrophy versus hyperplasia, wemeasured the capacity of
adipocyte precursors in the stromal-vascular fraction to undergo de
novo adipogenesis. We could show that inguinal SVF had an eight fold
higher potential to differentiate into lipid-droplet containing adipocytes
than epididymal SVF (Fig. 1a,b) as quantiﬁed by the number of lipid
droplet positive cells which might be due to an increased number of
adipocyte precursor cells within the inguinal SVF. Thus, to compare
precursor numbers in the inguinal and epididymal compartment, the
Lin−CD29+CD34+Sca1+ cell population, which is commonly accepted
as a population deﬁning adipocyte precursors, was analyzed by ﬂow cy-
tometry in the different fat compartments. Surprisingly, we observed a
higher number of adipocyte precursor cells in the epididymal compart-
ment, a ﬁndingwhich is at oddswith the reduced capacity of these cells
to differentiate (Fig. 1c–e). Taken together we could show that epididy-
mal adipose tissue precursor cells have a reduced capacity to differenti-
ate into mature adipocytes.
As adipocyte precursor numbers do not seem to account for the im-
paired differentiation capacity in epididymal adipose tissue, we hypoth-
esized that other cells present in the SVF secrete factors modulate
adipocyte differentiation in a paracrine fashion. Therefore, differentiationFig. 4. Adenoviral knockdown of Decorin and Sparcl1 on 3T3L1, inguinal and epididymal SVF. a)
represents an shRNA depicting the mean of three individual experiments per shRNA (n= 3). b
candidates for 48 h. Each point represents an shRNA analyzed depicting themean of three indiv
infection of 3T3-L1 cells for Dcn. For each condition the mean of three individual wells is pres
secreted Dcn. Coomassie stain was used to ensure equal loading. Each lane represents one in
epididymal SVF upon adenoviral knockdown of Dcn1 48 h before induction of differentiation.
For each condition the mean of three individual wells is presented. g) WBlot analysis of adeno
was used to ensure equal loading. Each lane represents one individual well infected with
adenoviral knockdown of Sparcl1 48 h before induction of differentiation. qPCR results were n
two tailed unpaired t-test, *p b 0.05.assays with conditioned media from inguinal and epididymal SVF were
performed. We could show that differentiation in conditioned media
from inguinal and epididymal SVF lowered adipocyte numbers in
inguinal SVF to 24% and 12% of the original differentiation capacity,
respectively (Fig. 2a,b). In contrast, we observed again low levels of
differentiation in the epididymal SVF, and no effect was observed by
the presence of conditioned media (Fig. 2a,b). To determine the nature
of the inhibitory factors present in the supernatant, the experiment
was repeated with conditioned media that had been heat inactivated
for 10 min at 95 °C, which reversed the inhibitory effect completely
for the supernatant from inguinal SVF and to a large extent for the super-
natant from epididymal SVF (Fig. 2a,b). Based on these results we hy-
pothesize that secreted factors from the SVF of epididymal adipose
tissue inhibit adipocyte differentiation in a paracrine fashion.
In order to identify secreted proteins from the SVF, we analyzed
supernatant from cultured inguinal and epididymal SVF by mass
spectrometry. Approximately 60% of identiﬁed peptides were derived
from secreted proteins. Out of 89 secreted proteins in the supernatant
of inguinal SVF and 72 proteins in the epididymal supernatant, 48
proteins were found to be secreted from both compartments corre-
sponding to anoverlap of 42% (Fig. 3a, Suppl. Table 4). Using thepanther
classiﬁcation system on all identiﬁed proteins, the biggest group of
proteins was classiﬁed as extracellular matrix proteins followed by the
functional class of receptors (Fig. 3b). Analysis using the Webgestalt
resource gave similar results (data not shown).
To narrow down the list of potential candidates, proteins that had
previously been shown to promote adipocyte differentiation were
discarded from the candidate list. To further narrow down interesting
candidates that potentially lead to a strong inhibition of adipogenesis
in epididymal SVF, we next analyzed mRNA expression levels of the
remaining 45 proteins in inguinal and epididymal SVF by qPCR.
Normalization to β-actin or Gapdh essentially led to the same results
(Fig. 3c, Supplementary Fig. 1). mRNA levels of 16 proteins were
signiﬁcantly upregulated in epididymal compared to inguinal SVF
and were included in a secondary functional screen. Given the fact
that protein activity can be regulated by other means than only
mRNA expression, 6 further candidates were included into the adi-
pocyte differentiation screen that had previously been described to
modulate differentiation processes. For each of these proteins,
three different shRNAs were designed and used for adenovirus pro-
duction whichwere analyzed in 3 independent experiments. Addition-
ally, adenovirus expressing scrambled shRNA (negative control), GFP-
overexpressing adenovirus (transfection control) and adenovirus
expressing shRNA against Timp1 (positive control) were generated.
Puriﬁed adenoviruses were used for infection of inguinal and epididy-
mal SVF as well as 3T3-L1 preadipocytes (Supplementary Fig. 2).
As shown in Fig. 4a, several proteins showed an effect of some of the
shRNAs tested suggesting that they might be inhibitors of adipogenesis
as knockdown might induce adipocyte formation. In addition,
knockdown of some of the candidates led to a reduction in adipocyte
formation, but given the induced expression we did not study these
proteins any further. We considered proteins to be inhibitors of
adipogenesis if at least 1 shRNA in 3T3L1 led to an induction of
5 SDs (2.35fold induction) over control. Using this ﬁltering method,
4 candidates were identiﬁed which were subsequently tested in
primary epididymal preadipocytes (Fig. 4b). Decorin (Dcn), andAnalysis of differentiation of 3T3-L1 cells after adenoviral knockdown for 48 h. Each point
) Analysis of differentiation of epididymal SVF after adenoviral knockdownwith indicated
idual experiments per shRNA (n=3). c) qPCR analysis of adenoviral knockdown 48 h after
ented. d) WBlot analysis of adenoviral knockdown 48 h after infection of 3T3-L1 cells for
dividual well infected with control or Dcn adenovirus. e) Differentiation of inguinal and
f) qPCR analysis of adenoviral knockdown 48 h after infection of 3T3-L1 cells for Sparcl1.
viral knockdown 48 h after infection of 3T3-L1 cells for secreted Sparcl1. Coomassie stain
control or Sparcl1 adenovirus h) Differentiation of inguinal and epididymal SVF upon
ormalized to Gapdh. The mean of three individual experiments are represented (n = 3),
Fig. 5. Inguinal and epididymal SVF differentiation in the presence of murine recombinant protein for Dcn (a,c) and Sparcl1 (b,d). Protein was added one day before and 2 days after
induction of differentiation. Cells were ﬁxed and stained at day 7 of differentiation. (n = 3) *p b 0.05 **p b 0.01 ***p b 0.001.
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SVF (Supplementary Fig. 3) and knock down which was demonstrat-
ed on mRNA as well as protein level (Fig. 4c,d,f,g) showed a propen-
sity to induce differentiation (Fig. 4e,h). Interestingly, we observedonly mild changes in differentiation when these factors were ablated
in inguinal primary pre-adipocytes (Fig. 4e,h) which is in line with
our original assumption that these factors are inhibitors of epididy-
mal adipogenesis.
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nal and epididymal SVFwith recombinant protein duringdifferentiation
and quantiﬁed the regulation of this process. As shown in Fig. 5a,b we
could demonstrate that both proteins in accordance with the gene
knock down data inhibited differentiation in a dose dependent manner
(Fig. 5c,d) suggesting that they are indeed inhibitors of adipogenesis
and might contribute to the reduced capacity of epididymal adipose
tissue to differentiate.
Taken together we have identiﬁed several new factors preferentially
secreted from epididymal SVF which seem to inhibit the process of
adipocyte differentiation. Together with the data demonstrating the
enhanced release from epididymal SVF we propose that these factors
play an important role in the different propensity of inguinal and
epididymal adipose tissue to differentiate.
4. Discussion
Adipocyte precursor cells are responsible for de novo adipocyte for-
mation in adipose tissue growth. We and others show that the capacity
of adipose tissue to generate new adipocytes is dependent on the fat
depot-murine subcutaneous fat having a greater adipogenic potential
than visceral adipose tissue [18]. In the current study the inguinal
depot was used as a representative of a subcutaneous depot while epi-
didymal adipose tissuewas used as a representative for visceral adipose
tissue. Inmale adult mice, the impaired differentiation capacity of intra-
abdominal adipose tissue is accompanied by an increased adipocyte size
in epididymal compared to subcutaneous fat depots. Interestingly,
Tchkonia et al. [19] also observed differences in adipogenic potential
in a small cohort of human female and male obese subjects. In this
study, subcutaneous adipocyte precursor based on the lineage reported
by Rodeheffer et al. [20] cells seem to be increased in visceral adipose
tissue. Interestingly however, subcutaneous SVF derived precursors
show highest adipogenicity followed by SVF from epididymal adipose
tissue, thus mirroring the results in mice. Interestingly this is in line
with a report by Macotela et al. which showed that in obesity the num-
bers of precursors increased and that the block in differentiation capac-
ity could be overcome by the addition of external signaling molecules
such as Bmp4 [21]. Adding to the hypothesis of depot-speciﬁc differ-
ences, Permana et al. show in a cohort of obese Pima Indians that subcu-
taneous differentiation is inversely correlated with central obesity [22].
It can therefore be speculated that a high differentiation capacity in sub-
cutaneous adipose tissue can buffer excess energy and prevent accumu-
lation of intra-abdominal fat, which poses a greater risk factor for
metabolic complications [16,23,24]. Furthermore, it is possible that
cells from other lineages contribute to the observed effect.
The capacity to rebuild new adipocytes also seems to be age depen-
dent, as epididymal SVF of youngmice show a rate of in vitro adipocyte
differentiation similar to that of subcutaneous SVF [25] (own observa-
tions not shown). In prepubertal children high differentiation rates
can be detected in subcutaneous and visceral SVF [26] and adipocyte
cell numbers increase rapidly in lean and even more pronounced in
obese children [27]. Furthermore, young women have a higher total
fat cell number compared to older women within the same BMI range
[28], thereby supporting the hypothesis of declining adipocyte differen-
tiation with age [29]. When studying adipogenic processes it is there-
fore informative to investigate fat depot-speciﬁc differences also in the
context of age and sex.
It has been shown that secreted factors from adipose tissue modu-
late adipocyte differentiation. The majority of studies, however, investi-
gated the inﬂuence of secreted factors from isolated adipocytes on
adipocyte differentiation [30–32], whereas secreted factors from the
stromal-vascular cell fraction of adipose tissue are largely neglected.
A recent study by us analyzing pure adipocytes from both depots for
their secretory capacity showed no overlap with factors observed in
the current study, suggesting that indeed both types of cells secrete dif-
ferent sets of factors [32]. Two studies address the impact of endothelialcells on adipogenesis of human or rat SVF with different outcome,
maybe due to species differences or different culture conditions
[33,34]. Here we show that heat-sensitive factors from SVF inhibit
adipogenesis in primary adipocyte precursor cells suggesting a
protein mediated effect. Furthermore, the observed effect is more
pronounced in visceral compared to subcutaneous SVF, which
could be part of the reason for the enhanced adipogenic potential
of subcutaneous compared to visceral SVF. Given the fact that the
adipogenic rate is very low in epididymal adipose tissue it is further-
more possible that factors secreted from this compartment aremain-
ly responsible for the differences between both depots. Nevertheless
these difference also pose a limitation as the effect size in visceral
adipose tissue is signiﬁcantly smaller than in subcutaneous adipose
tissue. In fact, in the hematopoietic stem cell ﬁeld it is a well-
established concept that stem cells can switch from a dormant to
and active self-renewing state dependent on their microenviron-
ment [35]. This concept might be true in a similar way for adipocyte
progenitor cells, especially given the fact that progenitor cell
numbers do not differ between subcutaneous and visceral SVF.
Under the assumption that secreted proteins are responsible for the
inhibitory effect, we performedmass spectrometry analysis of superna-
tant from subcutaneous and visceral SVF. Many studies explore protein
secretion from adipose tissue, oftenwith a focus on adipocytes or whole
adipose tissue explants [36,37]. The secretome of isolated human SVF or
3T3-L1 preadipocytes has also been analyzed in several reports [38,39].
However, these studies are focused on identifyingdifferentially secreted
proteins during adipocyte differentiation, but none of the identiﬁed
proteins has been characterized further with regard to their function
in adipogenesis. Here, we combine an unbiased identiﬁcation approach
of secreted proteins from murine SVF with a functional analysis in
adipocyte differentiation. Knockdown of four proteins led to enhanced
adipocyte differentiation in primary SVF and in further studies we
could show that exogenous addition of Dcn and Sparcl1 led to the inhi-
bition of adipogenesis. Interestingly, both factors are expressed atmuch
lower levels in the subcutaneous SVF and in line with this knock down
of either factor in SVF from the subcutaneous depot did not show any
effect. Addition of the exogenous protein had an effect on SVF from
both depots suggesting that the downstream targets are expressed
which would allow for cross-talk between both depots. Whereas for
none of the identiﬁed proteins a direct inﬂuence on adipocyte differen-
tiation has been shown so far, some are described to be regulated during
the differentiation process. Furthermore, many of the identiﬁed pro-
teins are functionally interconnected, potentially forming a cluster of
proteins regulating adipogenesis. Dcn is an extracellular small leucine-
rich proteoglycans that bind to a variety of collagens [40,41] and to
transforming growth factor β (TGFβ) [42]. Dcn modulates attachment
of dermal ﬁbroblasts to ﬁbronectin [43] and is implicated in collagen
ﬁbril formation [44] as well as preadipocyte proliferation [45]. Given
the fact that ﬁbronectin and different types of collagen are important
modulators of adipocyte differentiation [46], this is a likely pathway
by which Dcn inhibits adipocyte differentiation. Lastly, Dcn is secreted
with a pro-peptide that can be cleaved off by bone morphogenic
protein 1 (Bmp1), another protein that has been identiﬁed in our
functional screen. Secreted protein acidic and rich in cysteine like-1
(Sparcl1/hevin) is a calcium-modulated protein that binds to colla-
gen type I [47]. In vitro, Sparcl1 blocks cell proliferation and has
been suggested as a tumor suppressor gene [48]. Interestingly,
Sparcl1 modulates collagen ﬁbril formation and stimulates Dcn
secretion in the dermis [49], a mechanism that has not been investi-
gated in adipose tissue so far. On the other hand, the closely related
protein Sparc is highly expressed in adipose tissue and negatively
regulates adipogenesis and fat accumulation [50,51].
In conclusion we show here that Dcn and Sparcl1 are both enriched
in visceral preadipocytes which correlates with a reduced propensity of
these cells to differentiate. As both factors inhibit adipogenesis it is
possible that the reduced adipogenic capacity of visceral preadipocytes
1130 B. Meissburger et al. / Biochimica et Biophysica Acta 1861 (2016) 1121–1131is due at least in part to changes in Dcn and Sparcl1 possibly through
alterations in the ECM formation. Given the close interaction with
extracellular matrix structures, it will be instructive to study extracellu-
lar matrix, intracellular cytoskeleton structure and cell adhesion via
β-integrins in order to shed light on the mechanistic processes
inhibiting adipogenesis.
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